Journals / Türk Biyokimya Dergisi / 2021 / Cilt: 46 - Sayı: 5

Evaluation of new sulfathiazole derivatives as antiproliferative agents

Yeni sülfatiyazol türevlerinin antiproliferatif ajan olarak değerlendirilmesi

Pages
533–539
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Target compounds exhibited high to mode- rate antiproliferative activity and they displayed higher MMP-9 inhibition than cathepsin inhibition activity. 2b and 2e were identified as the most active compounds when evaluated, biologically

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Sulfonamide group is an important scaffold used for generating new building blocks with diverse bio- logical activities.
📊
Key Findings & Data:Materials and methods: Compounds 2a–g were synthe- sized using a two-step synthetic procedure starting from commercially available sulfathiazole.
💡
Conclusion & Impact:Conclusions: Target compounds exhibited high to mode- rate antiproliferative activity and they displayed higher MMP-9 inhibition than cathepsin inhibition activity. 2b and 2e were identified as the most active compounds when evaluated, biologically
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Sulfonamide group is an important scaffold used for generating new building blocks with diverse bio- logical activities. Considering priority of the sulfonamide structure, seven new sulfathiazole derivatives were synthesized and evaluated for their antiproliferative acti- vity, in this study. Materials and methods: Compounds 2a–g were synthe- sized using a two-step synthetic procedure starting from commercially available sulfathiazole. The antiprolifera- tive activity of the compounds was investigated against A549 and NIH/3T3 cell lines by MTT assay, matrix metalloproteinase-9 (MMP-9) and cathepsin inhibition tests. Results: Compound 2b bearing triazole ring exhibited highest inhibitory activity (IC 50 : 12.33 μg/mL) with selective profile which was better than cisplatin and it also inhibited MMP-9 with 53.67% percentage. Compounds 2c and 2e inhibited cathepsin L with percentages of 62.75 and 57.25%, whereas cathepsin D was poorly inhibited by the compounds. Conclusions: Target compounds exhibited high to mode- rate antiproliferative activity and they displayed higher MMP-9 inhibition than cathepsin inhibition activity. 2b and 2e were identified as the most active compounds when evaluated, biologically

Özet

Amaç: Sülfonamid grubu, çeşitli biyolojik aktivitelere sahip yeni yapı taşları üretmek için kullanılan önemli bir yapı iskelesidir. Sülfonamid yapısının öncüliğü göz önüne alınarak, bu çalışmada yedi yeni sülfatiyazol türevi sentez- lenmiş ve antiproliferatif aktiviteleri değerlendirilmiştir. Gereç ve Yöntem: 2a–g bileşikleri, ticari olarak sağlanan sülfatiyazolden başlanarak iki aşamalı sentetik bir prose- dürle sentezlenmiştir. Bileşiklerin antiproliferatif aktivite- leri A549 ve NIH/3T3 hücre dizilerine karşı MTT deneyi, matriks metaloproteinaz-9 (MMP-9) ve katepsin inhibisyon testleri ile belirlenmiştir. Bulgular: Triazol halkası taşıyan bileşik 2b, sisplatinden daha fazla olmak üzere seçici profile sahip en yüksek inhibitör aktiviteyi (IC 50: 12.33 μg/mL) sergilemiştir ve MMP-9’u % 53.67 ile inhibe etmiştir. Bileşik 2c ve 2e % 62.75 ve % 57.25’lik oranlarla katepsin L’yi inhibe ederken katepsin D bileşikler tarafından zayıf bir şekilde inhibe edilmiştir. Sonuç: Hedef bileşikler, yüksek ila orta derecede antip- roliferative aktivite sergilemiş ve katepsin inhibisyonuna göre daha yüksek MMP-9 inhibisyonu göstermiştir. Biyo- lojik açıdan değerlendirildiğinde 2b ve 2e en aktif bile- şikler olarak tespit edilmiştir.

🔖

Cite This Article

Çiftçi, G. A., Yurttaş, L., Temel, H. E. (2022). Evaluation of new sulfathiazole derivatives as antiproliferative agents. Türk Biyokimya Dergisi, Cilt: 46 - Sayı: 5, 533–539. https://ajindex.com/articles/620704

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Rakesh KP, Wang SM, Leng J, Ravindar L, Asiri AM, Marwani HM, et al. Recent development of sulfonyl or sulfonamide hybrids as potential anticancer agents: a key review. Anti Canc Agents Med Chem 2018;8:488–505
  2. Raju TNK. The Nobel chronicles. Lancet 1999;353:681
  3. Hansch C, Sammes PG, Taylor JB, editors Comprehensive medicinal chemistry. Oxford: Pergamon Press; 1990
  4. Bryant B, Knights K, editors. Pharmacology for health professionals, 3rd ed. Pharmacology, Australia: Elsevier; 2011, vol 3:645 p
  5. Zhao C, Rakesh KP, Ravidar L, Fang WY, Qin HL. Pharmaceutical and medicinal significance of sulfur (SVI)-containing motifs for drug discovery: a critical review. Eur J Med Chem 2019;162: 679–734
  6. Firake SD, Bari SB. Scaffold revealing COX-2 inhibitors, an insight into synthetic and docking approaches of benzenesulfonamide. Curr Enzym Inhib 2015;11:76–107
  7. Kha A, Mushtaq S, Naz S, Farooq U, Zaidi A, Bukhari SM, et al. Sulfonamides as potential bioactive scaffolds. Curr Org Chem 2018;22:818–30
  8. Yurttaş L, Akalın-Çiftçi G. New quinoline based sulfonamide derivatives. Anti Canc Agents Med Chem 2018;18:1122–30
  9. Apaydın S, Török M. Sulfonamide derivatives as multi-target agents for complex diseases. Bioorg Med Chem Lett 2019;29: 2042–50
  10. Sroor FM, Abdelmoniem AM, Abdelhamid IA. Facile synthesis, structural activity relationship, molecular modeling and in vitro biological evaluation of new urea derivatives with incorporated isoxazole and thiazole moieties as anticancer agents. ChemistrySelect 2019;4:10113–21
  11. Groutas WC, He S, Kuang R, Ruan S, Tu J, Chan HK. Inhibition of serine proteases by functionalized sulfonamides coupled to the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold. Bioorg Med Chem 2001;9:1543–8
  12. Ramazani A, Sadighian H, Gouranlou F, Joo SW. Syntheses and biological activities of triazole-based sulfonamides. Curr Org Chem 2019;23:2319–49
  13. Pesaran A, Bonakdar S, Vafaei F, Farokhpour M, Hossein M, Esfahanic N, et al. Synthesis and anticancer activity assay of novel chalcone-sulfonamide derivatives. Iran J Pharm Res (IJPR) 2017;16:565–8
  14. El‐Helby AGA, Sakr H, Eissa IH, Abulkhair H, Al‐Karmalawy AA, El‐Adl K. Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors. Arch Pharm Chem Life Sci 2019;352:1900113
  15. Sondhi SM, Johar M, Singhal N, Dastidar SG, Shukla R, Raghubir R. Synthesis and anticancer, antiinflammatory, and analgesic activity evaluation of some